Salvage of long-term central venous catheters during an outbreak of Pseudomonas putida and Stenotrophomonas maltophilia infections associated with contaminated heparin catheter-lock solution

Infection Control and Hospital Epidemiology

Volumn 29, Issue 2, 2008, Pages 125-130

  Dias, M Beatriz Souza ^a   Habert, Alina Bernardes ^a   Borrasca, Vera ^a   Stempliuk, Valeska ^a   Ciolli, Aina ^a   Araújo, M Rita E ^a   Costa, Silvia F ^a   Levin, Anna S ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIINFECTIVE AGENT; CARBAPENEM DERIVATIVE; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; HEPARIN; LEVOFLOXACIN; MEROPENEM;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTEREMIA; BACTERIUM ISOLATE; BLOOD CULTURE; BLOOD SAMPLING; CANCER PATIENT; CATHETER REMOVAL; CENTRAL VENOUS CATHETER; CHILD; CONTAMINATION; FEMALE; FOLLOW UP; GRAM NEGATIVE INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR TYPING; PATIENT CARE; PSEUDOMONAS PUTIDA; PULSED FIELD GEL ELECTROPHORESIS; SALVAGE THERAPY; STENOTROPHOMONAS MALTOPHILIA; SYRINGE; TERTIARY HEALTH CARE;

EID: 39449094613     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/526440     Document Type: Article

References (32)

1. Wade JC, Newman KA, Schimpff SC, et al. Two methods for improved venous access in acute leukemia patients. JAMA 1981; 246:140-144.
2. Rubenstein EB, Fender A, Rolston KVI, et al. Vascular access by physician assistants: evaluation of an implantable peripheral port system in cancer patients. J Clin Oncol 1995; 13:1513-1519.
3. Sotir MJ, Lewis C, Bisher EW, Ray SM, Soicie JM, Blumberg HM. Epidemiology of device-associated infections related to a long-term implantable vascular access device. Infect Control Hosp Epidemiol 1999; 20:187-191.
4. Prospero E, Barbadoro P, Savini S, Manso E, Annino I, D'Errico MM. Cluster of Pseudomonas aeruginosa catheter-related bloodstreams infections traced to contaminated multidose heparinized saline solutions in a medical ward. Int J Hyg Environ Health 2006; 209:553-556.
5. Hsueh PR, Teng LJ, Pan HJ, et al. Outbreak of Pseudomonas fluorescens bacteremia among oncology patients. J Clin Microbiol 1998; 36:2914-2917.
6. Torii K, Noda Y, Miyazaki Y, Ohta M. An unusual outbreak of infusionrelated bacteremia in a gastrointestinal disease ward. Jpn J Infect Dis 2003; 56:177-178.
7. Kimura AC, Calvet H, Higa JI, et al. Outbreak of Ralstonia pickettii bacteremia in a neonatal intensive care unit. Pediatr Infect Dis J 2005; 24:1099-1103.
8. Perz JF, Craig AS, Strattin CW, Bodner SJ, Phillips WE Jr, Schaffner W. Pseudomonas putida septicemia in a special care nursery due to contaminated flush solutions prepared in a hospital pharmacy. J Clin Microbiol 2005; 43:5316-5318.
9. Centers for Disease Control and Prevention. Pseudomonas bloodstream infections associated with a heparin/saline flush-Missouri, New York, Texas, and Michigan, 2004-2005. MMWR Morb Mortal Wkly Rep 2005; 54:269-272.
10. Albo Lopez C, Lopez Rodriguez D, Constenla Camba MI, Jimenez Blanco A, Araujo LF, Garcia-Medina J. Infectious and non-infectious complications of tunneled central catheters in hematologic patients [in Spanish]. Sangre (Barc) 1999; 44:176-181.
11. Biffi R, de Braud F, Orsi F, et al. Totally implantable central venous access ports for long-term chemotherapy: a prospective study analyzing complications and cost of 333 devices with a minimum follow-up of 180 days. Ann Oncol 1998; 9:767-773.
12. National Committee for Clinical Laboratory Standards (NCCLS). Reference Standards for Antimicrobial Susceptibility Testing. Wayne, PA: NCCLS; 2002:M100-59.
13. Sambrook, J, Fritsch EF, Maniatis T. Molecular Cloning, a Laboratory Manual. 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1989.
14. Renders N, Romling Y, Verbrugh H, Van Belkum A. Comparative typing of Pseudomonas aeruginosa by random amplification of polymorphic DNA or pulsed-field gel electrophoresis of DNA macrorestriction fragments. J Clin Microbiol 1996; 34:3190-3195.
15. Tenover, F, Arbeit R, Goering R, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33:2233-2239.
16. Centers for Disease Control and Prevention. Exophiala infection from contaminated injectable steroids prepared by a compounding pharmacy - United States, July-November 2002. MMWR Morb Mortal Wkly Rep 2002; 51:1109-1112.
17. Aumeran C, Paillard C, Robin F, et al. Pseudomonas aeruginosa and Pseudomonas putida outbreak associated with contaminated water outlets in an oncohaematology paediatric unit. J Hosp Infect 2007; 65:47-53.
18. Romney M, Sherlock C, Stephens G, Clarke A. Pseudo-outbreak of Pseudomonas putida in a hospital outpatient clinic originating from a contaminated commercial anti-fog solution - Vancouver, British Columbia. Can Commun Dis Rep 2000; 26:183-184.
19. Agência Nacional de Vigilância Sanitária (ANVISA). Resolução da Diretoria Colegiada- RDC no. 214, de 12 de Dezembro de 2006. Dispõe sobre Boas Práticas de Manipulação de Medicamentos para Uso Humano em farmácias. Available at: http://e-legis.anvisa.gov.br/leisref/public/showAct.php?id=25128&word=. Accessed May 24, 2007.
20. Valdezate S, Vindel A, Martin-Davila P, Del Saz BS, Baquero F, Canton R. High genetic diversity among Stenotrophomonas maltophilia strains despite their originating at a single hospital. J Clin Microbiol 2004; 42:693-699.
21. Klausner JD, Zukerman C, Limaye AP, Corey L. Outbreak of Stenotrophomonas maltophilia bacteremia among patients undergoing bone marrow transplantation: association with faulty replacement of handwashing soap. Infect Control Hosp Epidemiol 1999; 20:756-758.
22. Gulcan H, Kuzuku C, Durmaz R. Nosocomial Stenotrophomonas maltophilia cross-infection: three cases in newborns. Am J Infect Control 2004; 32: 365-368.
23. Sakhnini E, Weissmann A, Oren I. Fulminant Stenotrophomonas maltophilia soft tissue infection in immunocompromised patients: an outbreak transmitted via tap water. Am J Med Sci 2002; 323: 269-272.
24. Verweij PE, Meis JF, Christmann V, et al. Nosocomial outbreak of colonization and infection with Stenotrophomonas maltophilia in preterm infants associated with contaminated tap water. Epidemiol Infect 1998; 120:251-256.
25. Weber DJ, Rutala WA, Blanchet CN, Jordan M, Gergen MF. Faucet aerators: a source of patient colonization with Stenotrophomonas maltophilia. Am J Infect Control 1999; 27:59-63.
26. Rogues AM, Maugein J, Allery A, et al. Electronic ventilator temperature sensors as a potential source of respiratory tract colonization with Stenotrophomonas maltophilia. J Hosp Infect 2001; 49:289-292.
27. Labarca JA, Leber AL, Kern VL, et al. Outbreak of Stenotrophomonas maltophilia bacteremia in allogenic bone marrow transplant patients: role of severe neutropenia and mucositis. Clin Infect Dis 2000; 30:195-197.
28. Alfieri N, Ramotar K, Armstrong P, Spornitz ME, Ross G, Winnick J, Cook DR. Two consecutive outbreaks of Stenotrophomonas maltophilia (Xanthomonas maltophilia) in an intensive-care unit defined by restriction fragment-length polymorphism typing. Infect Control Hosp Epidemiol 1999; 20:553-556.
29. Hanna H, Afif C, Alakech B, et al. Central venous catheter-related bacteremia due to gram-negative bacilli: significance of catheter removal in preventing relapse. Infect Control Hosp Epidemiol 2004; 25:646-649.
30. Fatkenheuer G, Cornely O, Seifert H. Clinical management of catheter-related infections. Clin Microbiol Infect 2002; 8: 545-550.
31. Lee MY, Ko KS, Song JH, Peck KR. In vitro effectiveness of the antibiotic lock technique (ALT) for the treatment of catheter-related infections by Pseudomonas aeruginosa and Klebsiella pneumoniae. J Antimicrob Chemother 2007; 60:782-787.
32. Ma Q, Zhai Y, Schneider JC, Ramseier TM, Saier MH. Protein secretion systems of Pseudomonas aeruginosa and P. fluorescens. Biochim Biophys Acta 2003; 1611: 223-233.